ARB2A and neoplasm: Similarly, we observed that FAM172A knockdown reduced tumor growth, metastatic nodule formation, and modulated proliferation and invasion-related protein expression in EOC, supporting its potential as a therapeutic target to suppress EOC progression and metastasis.